CERo Therapeutics Holdings, Inc. (CERO)

NASDAQ: CERO · IEX Real-Time Price · USD

1.370

-0.040 (-2.84%)

At close: Apr 26, 2024, 4:00 PM

1.380

+0.010 (0.73%)

After-hours: Apr 26, 2024, 7:57 PM EDT

CERO Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021
Market Capitalization	20	69	236	228
Market Cap Growth	-	-70.89%	3.64%	-
Enterprise Value	13	62	195	212
PE Ratio	-27.09	-27.09	-353.47	-21.42
PB Ratio	-4.84	-4.84	-21.46	-9.72
P/FCF Ratio	-45.10	-45.10	-216.09	-21.27
P/OCF Ratio	-45.10	-45.10	-216.09	-22.56
EV/EBITDA Ratio	-25.28	-25.28	-2836.70	-21.44
EV/EBIT Ratio	-25.28	-25.28	-2836.70	-19.96
EV/FCF Ratio	-40.52	-40.52	-178.10	-19.81
Debt / Equity Ratio	-0.11	-0.11	-0.06	-0.15
Debt / EBITDA Ratio	-0.64	-0.64	-9.48	-0.36
Debt / FCF Ratio	-1.02	-1.02	-0.60	-0.34
Quick Ratio	1.65	1.65	1.37	10.45
Current Ratio	1.66	1.66	1.38	10.62
Return on Equity (ROE)	12.70%	12.70%	7.40%	-
Return on Assets (ROA)	-23.40%	-23.40%	-0.50%	-
Return on Capital (ROIC)	23.20%	23.20%	28.07%	58.59%
Earnings Yield	-12.57%	-3.69%	-0.28%	-4.67%
FCF Yield	-7.55%	-2.22%	-0.46%	-4.70%
Buyback Yield / Dilution	70.97%	70.97%	-150.43%	-
Total Shareholder Return	70.97%	70.97%	-150.43%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).